6-Chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid

Catalog No.: 
ACKTYW830
CAS No.: 
1314903-71-3
Molecular Formula: 
C7H4ClN3O2
Molecular Weight: 
197.58
6-Chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$84.00In stockInquiry
5g98%$312.00In stockInquiry
25g98%$1136.00In stockInquiry
100g98%$2929.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid
IUPAC Name6-chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid
MDL No.MFCD11042721
Molecular FormulaC7H4ClN3O2
Molecular Weight197.58
SMILESO=C(C1=NNC2=C1C=NC(Cl)=C2)O
InChI KeyHQHSKXNZULRANW-UHFFFAOYSA-N
Synonym6-chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid;1H-Pyrazolo[4,3-c]pyridine-3-carboxylic acid, 6-chloro-;6-chloro-1H-pyrazolo[4,3-c]pyridine-3-carboxylic acid - [C82309]
CAS No.1314903-71-3
PubChem CID55264664

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKTYW830 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDXEA205 route compound structure diagram
    ACDXEA2051658461-71-2In Stock
  2. Then
  3. ACKTYW830 route product structure diagram
    ACKTYW8301314903-71-3In Stock
Inquiry

2. ACKTYW830 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKTYW830 route product structure diagram
    ACKTYW8301314903-71-3In Stock
Inquiry

3. ACKTYW830 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKTYW830 route product structure diagram
    ACKTYW8301314903-71-3In Stock
Inquiry

Comments (0)